MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.atherosclerosis.2015.11.032

Медицинская библиотека · Atherosclerosis · 2015

Longer duration of statin therapy is associated with decreased carotid plaque vascularity by magnetic resonance imaging.

O'Brien Kevin D, Hippe Daniel S, Chen Huijun, Neradilek Moni B, Probstfield Jeffrey L, Peck Suzanne, Isquith Daniel A, Canton Gador, Yuan Chun, Polissar Nayak L, Zhao Xue-Qiao, Kerwin William S

СтатьяМногоцентровое исследованиеРандомизированное исследованиеПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

OBJECTIVE

Plaque neovasculature is a major route for lipoprotein and leukocyte ingress into plaques, and has been identified as a risk factor for carotid plaque disruption. Vp, a variable derived from pharmacokinetic modeling of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI), correlates with plaque neovasculature density. Because lipid-lowering therapy has been associated with regression of neovasculature in animal models, we sought to determine clinical correlates of carotid plaque neovasculature (as assessed by Vp) in participants on statin therapy for established cardiovascular disease.

METHODS

98 participants from an AIM-HIGH sub-study underwent DCE-MRI of their carotid arteries. Expert readers who were blinded to all clinical variables analyzed the MR images to measure carotid plaque Vp in all participants. Associations between Vp and duration of statin therapy and other clinical risk factors were analyzed.

RESULTS

Prior duration of statin treatment at enrollment ranged from <1 year (21%) 1-5 years (40%) and >5 years (39%). In univariate analyses, shorter duration of statin therapy (P = 0.01), the presence of metabolic syndrome (P = 0.02), and higher body mass index (P = 0.01) and lipoprotein(a) (P = 0.01) were all significantly associated with higher baseline Vp values. In multivariate analyses, significant associations remained between shorter duration of statin therapy (P = 0.004) and lipoprotein(a) (P = 0.04).

CONCLUSIONS

These are the first human, in vivo findings suggesting a relationship between duration of statin therapy and regression of carotid plaque neovasculature. Future longitudinal studies are warranted both to confirm this finding and to address whether changes in neovasculature may translate into change in risk for plaque disruption. CLINICALTRIALS.

GOV IDENTIFIERS: NCT00880178, NCT01178320 and NCT00120289.

Для цитирования: O'Brien Kevin D, Hippe Daniel S, Chen Huijun, Neradilek Moni B, Probstfield Jeffrey L, Peck Suzanne, Isquith Daniel A, Canton Gador, Yuan Chun, Polissar Nayak L, Zhao Xue-Qiao, Kerwin William S. Longer duration of statin therapy is associated with decreased carotid plaque vascularity by magnetic resonance imaging.. Atherosclerosis. 2015. DOI: 10.1016/j.atherosclerosis.2015.11.032.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.